These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 10783998)
1. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Pearce CB; Duncan HD; Timmis L; Green JR Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998 [TBL] [Abstract][Full Text] [Related]
2. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. el-Omar E; Penman I; Cruikshank G; Dover S; Banerjee S; Williams C; McColl KE Gut; 1994 Oct; 35(10):1385-8. PubMed ID: 7959192 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Parente F; Molteni P; Bollani S; Maconi G; Vago L; Duca PG; Rembacken B; Axon AT; Bianchi Porro G Scand J Gastroenterol; 1997 Nov; 32(11):1140-6. PubMed ID: 9399396 [TBL] [Abstract][Full Text] [Related]
4. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. Piodi LP; Bardella M; Rocchia C; Cesana BM; Baldassarri A; Quatrini M J Clin Gastroenterol; 2003 Jan; 36(1):22-5. PubMed ID: 12488702 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease. Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117 [TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. Halme L; Rautelin H; Leidenius M; Kosunen TU J Clin Pathol; 1996 Jan; 49(1):65-7. PubMed ID: 8666689 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel diseases. A case-control study. Rosania R; Von Arnim U; Link A; Rajilic-Stojanovic M; Franck C; Canbay A; Malfertheiner P; Venerito M J Gastrointestin Liver Dis; 2018 Jun; 27(2):119-125. PubMed ID: 29922755 [TBL] [Abstract][Full Text] [Related]
10. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Prónai L; Schandl L; Orosz Z; Magyar P; Tulassay Z Helicobacter; 2004 Jun; 9(3):278-83. PubMed ID: 15165265 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Guslandi M; Fanti L; Testoni PA Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929 [TBL] [Abstract][Full Text] [Related]
12. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
13. [The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study]. Song MJ; Park DI; Hwang SJ; Kim ER; Kim YH; Jang BI; Lee SH; Ji JS; Shin SJ Korean J Gastroenterol; 2009 Jun; 53(6):341-7. PubMed ID: 19556840 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and inflammatory bowel disease: is there a link? Papamichael K; Konstantopoulos P; Mantzaris GJ World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359 [TBL] [Abstract][Full Text] [Related]
15. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Wagtmans MJ; Witte AM; Taylor DR; Biemond I; Veenendaal RA; Verspaget HW; Lamers CB; van Hogezand RA Scand J Gastroenterol; 1997 Jul; 32(7):712-8. PubMed ID: 9246713 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. Ding ZH; Xu XP; Wang TR; Liang X; Ran ZH; Lu H PLoS One; 2021; 16(3):e0248427. PubMed ID: 33711050 [TBL] [Abstract][Full Text] [Related]
17. Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease. Mahmud N; Weir DG; Kelleher D Ir J Med Sci; 1999; 168(4):228-32. PubMed ID: 10624358 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study. Dilaghi E; Felici E; Lahner E; Pilozzi E; Furio S; Lucchini L; Quatrale G; Piccirillo M; Parisi P; Curto S; Annibale B; Ferretti A; Mennini M; Persechino S; Di Nardo G BMC Pediatr; 2024 Jun; 24(1):417. PubMed ID: 38951792 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease. Bartels LE; Jepsen P; Christensen LA; Gerdes LU; Vilstrup H; Dahlerup JF J Crohns Colitis; 2016 Apr; 10(4):443-8. PubMed ID: 26674958 [TBL] [Abstract][Full Text] [Related]